Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ewa Dworniczek has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence and β-Lactam Resistance of Enterobacterales Isolated from Urinary Samples in a Regional Hospital in Poland: Special Emphasis on Elderly Population

    by Łucja Dudzik, Paweł Migdał, Piotr Misiąg, Paweł Krzyżek, Ewa Dworniczek

    Urinary tract infections (UTIs) are among the most common bacterial infections worldwide. The growing prevalence of antimicrobial resistance among Enterobacterales, particularly to β-lactam antibiotics, contributes to treatment failures and prolonged hospital stays. This single-center descriptive surveillance study aimed to evaluate the distribution of Enterobacterales recovered from culture-positive urine samples in the Provincial Specialist Hospital in Włocławek, Poland, and to determine the prevalence of β-lactam resistance phenotypes among these isolates. Urine culture results collected between January and December 2025 from all hospital wards and the outpatient urology clinic were retrospectively analyzed in this study, with 1090 positive urine cultures included. For a subset of 85 isolates, microbiological findings were additionally linked with patients’ clinical characteristics. Bacteria of the genus Escherichia were the most frequently isolated (53.8%), followed by Klebsiella (22.9%) and Proteus (14.2%), with the remaining Enterobacterales genera recovered at frequencies ranging from 0.6% to 4.5%. Most isolates presented no detectable β-lactam resistance phenotype; however, resistance mediated by β-lactamase production was observed in some of them. Phenotypic ESBL and AmpC producers accounted for 25.3% and 0.6% of isolates, respectively, whereas phenotypic carbapenemase-producing strains were detected less frequently, with MBL and KPC producers representing 1.4% and 0.3% of isolates, respectively. No clear associations were identified between patient characteristics and the occurrence of specific bacterial isolates or resistance mechanisms, which may be explained by the relatively homogeneous study population, the majority of whom were ≥70 years old (66/85; 77.6%) and had a similar burden of comorbidities. In conclusion, the current level of β-lactam resistance phenotypes among urinary Enterobacterales in our setting can be considered moderate. Nevertheless, continuous surveillance of local urine-derived bacteria and their antimicrobial resistance profiles remains essential for optimizing effective control strategies.

  • Open Access

    A Review on the Current and Future State of Urinary Tract Infection Diagnostics

    by Łucja Dudzik, Paweł Krzyżek, Ewa Dworniczek

    Urinary tract infections (UTIs) constitute a severe global health problem, placing a significant burden on healthcare systems worldwide. These infections often lead to frequent hospitalizations, sick leaves, and serious post-infectious complications. One of the most critical aspects of UTI treatment is rapid and accurate identification of pathogens, which increasingly develop resistance to commonly used antibiotics, as well as to newer ones, despite the expectation of sustained efficacy. This alarming trend signals the widespread presence of strains equipped with multiple resistance factors. In this review, attention has been drawn to the current classification of UTIs based on age, gender, risk factors, and preferred treatment strategies. Additionally, this article reviews diagnostic solutions used in this matter, starting from those applied in routine diagnostics and ending with the latest, cutting-edge approaches that are gradually coming into use. Each method varies in its specificity, sensitivity, and costs of implementation, and therefore, the limitations associated with adopting these technologies in widespread UTI diagnostics are also discussed. The review emphasizes the need for further research to optimize these innovations and integrate them into broad clinical practice, ultimately enabling more effective combat against UTIs and limiting the spread of bacterial resistance.


  • Open Access

    Comparison of Cytotoxicity and Photocatalytic Properties of Iron Vanadate Nanoparticles with Commercial Catalysts: For the Degradation of Microplastics and Bacterial Inactivation Application

    by Guru Karthikeyan Thirunavukkarasu, Paweł Krzyżek, Adityanarayan Mohapatra, Ayeskanta Mohanty, Monika Motlochová, Michal Navrátil, Jaroslav Kupčík, Jan Šubrt, In-Kyu Park, Alicja Seniuk, et al.

    Microplastics (MPs) and the development of associated antibiotic-resistant bacteria are of serious concern. Conventional water treatment methodologies do not sufficiently address the issue of MPs and MPs-attached bacteria. The photocatalytic process is a promising technique that utilizes solar light to generate HO● radicals for the degradation of MPs and inactivation of microorganisms. In this work, the iron-vanadate (FeVO4, IVAN) nanoparticles prepared by the coprecipitation and a subsequent freeze-drying technique were tested for their cytotoxicity and photocatalytic activity in the degradation of MPs and inactivation of bacteria. Cytotoxicity of the prepared IVAN catalyst showed moderate toxicity levels at a concentration of 12.5 μg/mL. Photocatalytic degradation of catalysts evaluated using attenuated total reflection infrared (ATR-IR) spectroscopy revealed the overall highest increase in the carbonyl index (CI) and peroxyl index (PI) for the IVAN nanoparticles compared with commercial catalysts. The scavenging experiments confirmed that HO● and O2 ●- were the potential main reactive oxygen species produced during the photocatalytic process using IVAN. Furthermore, nuclear magnetic resonance (NMR) spectra proved an oxidative degradation of polystyrene (PS) MPs. Apparently, leaching of Fe and V ions closer to the acceptable toxicity levels was detected by using inductively coupled plasma optical emission spectrometry (ICP-OES). Interestingly, IVAN exhibited inhibition of the Staphylococcus aureus USA300 biofilm in both dark and light conditions. Therefore, our investigation of IVAN and commercial photocatalysts could give insights into the preparation of efficient catalysts for treating MPs and bacteria in water.


  • Open Access

    Mechanism of Action and Efficiency of Ag3PO4-Based Photocatalysts for the Control of Hazardous Gram-Positive Pathogens

    by Emil Paluch, Alicja Seniuk, Gustav Plesh, Jarosław Widelski, Damian Szymański, Rafał J. Wiglusz, Martin Motola, Ewa Dworniczek

    Silver phosphate and its composites have been attracting extensive interest as photocatalysts potentially effective against pathogenic microorganisms. The purpose of the present study was to investigate the mechanism of bactericidal action on cells of opportunistic pathogens. The Ag3PO4/P25 (AGP/P25) and Ag3PO4/HA (HA/AGP) powders were prepared via a co-precipitation method. Thereafter, their antimicrobial properties against Enterococcus faecalis, Staphylococcus epidermidis, and Staphylococcus aureus (clinical and reference strains) were analyzed in the dark and after exposure to visible light (VIS). The mechanism leading to cell death was investigated by the leakage of metabolites and potassium ions, oxidative stress, and ROS production. Morphological changes of the bacterial cells were visualized by transmission electron microscopy (TEM) and scanning transmission electron microscopy with energy-dispersive X-ray spectroscopy (SEM EDS) analysis. It has been shown that Ag3PO4-based composites are highly effective agents that can eradicate 100% of bacterial populations during the 60 min photocatalytic inactivation. Their action is mainly due to the production of hydroxyl radicals and photogenerated holes which lead to oxidative stress in cells. The strong affinity to the bacterial cell wall, as well as the well-known biocidal properties of silver itself, increase undoubtedly the antimicrobial potential of the Ag3PO4-based composites.


  • Open Access

    In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori

    by Maciej Spiegel, Paweł Krzyżek, Ewa Dworniczek, Ryszard Adamski, Zbigniew Sroka

    Helicobacter pylori is one of the most frequent human pathogens and a leading etiological agent of various gastric diseases. As stringent response, coordinated by a SpoT protein, seems to be crucial for the survivability of H. pylori, the main goal of this article was to use in silico computational studies to find phytochemical compounds capable of binding to the active site of SpoT from H. pylori and confirm the ability of the most active candidates to interfere with the virulence of this bacterium through in vitro experiments. From 791 natural substances submitted for the virtual screening procedure, 10 were chosen and followed for further in vitro examinations. Among these, dioscin showed the most interesting parameters (the lowest MIC, the highest anti-biofilm activity in static conditions, and a relatively low stimulation of morphological transition into coccoids). Therefore, in the last part, we extended the research with a number of further experiments and observed the ability of dioscin to significantly reduce the formation of H. pylori biofilm under Bioflux-generated flow conditions and its capacity for additive enhancement of the antibacterial activity of all three commonly used antibiotics (clarithromycin, metronidazole, and levofloxacin). Based on these results, we suggest that dioscin may be an interesting candidate for new therapies targeting H. pylori survivability and virulence.


  • Photo-responsive functional gold nanocapsules for inactivation of community-acquired, highly virulent, multidrug-resistant MRSA

    by Nanasaheb D. Thorat, Ewa Dworniczek, Grace Brennan, Grzegorz Chodaczek, Rabah Mouras, Victoria Gascón Pérez, Christophe Silien, Syed A. M. Tofail, Joanna Bauer

    The indiscriminate and sporadic use of antibiotics has contributed to the emergence of drug resistance phenomenon in bacteria including but not limited to Staphylococcus aureus. These drug-resistant bacteria have been threatening safety in hospitals and adversely affecting human health. Here we report a strategy to design photo-stimulated theranostic nanoprobes against methicillin-resistant Staphylococcus aureus (MRSA) “superbug” USA300. The nanocapsule probe is based on gold nanorods (GNRs) coated with pegylated thiol, mPEG-SH, which has been further modified by adding successively a natural antibacterial compound such as curcumin, and a cell targeting deoxyribonucleic acid (DNA) aptamer. We have used this novel gold nanocapsules for near-infrared (NIR) photophysical stimulation against pathogenic bacteria. We have found that the novel nanocapsule blocks biofilm formation and kills bacteria by photothermal action that causes disruption of the bacterial cell wall and membrane. In this approach, multiple drug-resistant Staphylococcus aureus has been captured by these nanocapsules through DNA aptamer targeting. All of the trapped bacteria could be killed in 30 minutes during the NIR stimulation due to the combination of photothermal effect, the generation of reactive oxygen species (ROS) and a loss of transmembrane potential (Δψ). Importantly we did not notice any resistance developed against the photothermal treatment. This is remarkable from an anti-biofilm activity point of view. Importantly, these multifunctional nanocapsules have also shown a surface enhanced Raman spectroscopy (SERS) effect, which could be used to evaluate the success of the inactivation effect during treatment. These results indicate that nanocapsule-based photo treatment can be an alternative antibacterial strategy without contributing to antibiotic resistance, and thus can be used for both environmental and therapeutic applications.